Figure 1
AL | CZ | FR | DE | UK | BA | BG | CY | NL | SK | LU | HU | MD | RS | EE | HR | LT | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Specialists | 0.02 | 0.03 | 0.04 | 0.04 | 0.05 | 0.05 | 0.06 | 0.08 | 0.08 | 0.09 | 0.10 | 0.12 | 0.12 | 0.13 | 0.14 | 0.19 | 0.44 |
AL | CZ | FR | DE | UK | BA | BG | CY | NL | SK | LU | HU | MD | RS | EE | HR | LT | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Specialists | 0.02 | 0.03 | 0.04 | 0.04 | 0.05 | 0.05 | 0.06 | 0.08 | 0.08 | 0.09 | 0.10 | 0.12 | 0.12 | 0.13 | 0.14 | 0.19 | 0.44 |
PAH continues to have limited survival despite improvements in therapy. ICU and 1-year mortality risk factors inclu… https://t.co/1mIVY8Lrue
Tel: +44 114 267 28 60
ERS © 2022 All rights reserved